Where China's Top Domestic & Multinational Clinical Development Leaders Meet

2021 Theme: China Biopharma Innovation's Inflection Point: Considering the Risks and Paths Forward

Despite a lingering global pandemic, China Biopharma innovation has steadfastly continued its march towards becoming a new hub where innovative first and best-in-class therapeutics are developed.

Have we reached an inflection point?

Join us November 10-12 in Shanghai as 450+ China clinical development leaders gather for deep and candid discussions on the most-pressing clinical development challenges!